Attached files

file filename
10-K - FORM 10-K - QUESTCOR PHARMACEUTICALS INCf55254e10vk.htm
EX-32 - EX-32 - QUESTCOR PHARMACEUTICALS INCf55254exv32.htm
EX-31 - EX-31 - QUESTCOR PHARMACEUTICALS INCf55254exv31.htm
EX-10.85 - EX-10.85 - QUESTCOR PHARMACEUTICALS INCf55254exv10w85.htm
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-134879, 333-114166, 333-102988, 333-85160, 333-61866, 333-25661, 333-32159, 333-23085, 333-17501, 333-03507, and 333-107755) and the Registration Statements on Form S-8 (Nos. 333-116624, 333-30558, 333-46990, 333-81243, 333-105694, 333-105693, 333-134878, and 333-151395), pertaining to the 1992 Stock Option Plan, the 1993 Non-Employee Directors’ Equity Incentive Plan, the 2000 Employee Stock Purchase Plan, the 2003 Employee Stock Purchase Plan, the 2004 Non-Employee Directors’ Equity Incentive Plan and the 2006 Equity Incentive Award Plan of Questcor Pharmaceuticals, Inc. of our reports dated March 15, 2010, with respect to the consolidated financial statements and schedule of Questcor Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Questcor Pharmaceuticals, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2009.
/s/ ODENBERG, ULLAKKO, MURANISHI & CO. LLP
San Francisco, California
DATE March 15, 2010